Once-weekly Glucagon-like Peptide-1 Receptor Agonists

Click Here to Read the Supplement 

This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D). 

Topics include:

• Burden of illness in patients with T2D
• Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
• Safety and clinical efficacy of GLP-1 RAs
• Implications of cardiovascular outcomes trials in T2D

Click Here to Read the Supplement

Click Here to Read the Supplement 

This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D). 

Topics include:

• Burden of illness in patients with T2D
• Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
• Safety and clinical efficacy of GLP-1 RAs
• Implications of cardiovascular outcomes trials in T2D

Click Here to Read the Supplement

Click Here to Read the Supplement 

This supplement provides an overview of the role of once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in type 2 diabetes (T2D). 

Topics include:

• Burden of illness in patients with T2D
• Pharmacokinetic properties and the mode and mechanism of action of GLP-1 RAs
• Safety and clinical efficacy of GLP-1 RAs
• Implications of cardiovascular outcomes trials in T2D

Click Here to Read the Supplement